These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1621747)

  • 1. Efficacy and safety of loracarbef in the treatment of pneumonia.
    Hyslop DL
    Am J Med; 1992 Jun; 92(6A):65S-69S. PubMed ID: 1621747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
    Hyslop DL; Jacobson K; Guerra FJ
    Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion.
    Foshee WS
    J Pediatr; 1992 Jun; 120(6):980-6. PubMed ID: 1593361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.
    Gan VN; Kusmiesz H; Shelton S; Nelson JD
    Antimicrob Agents Chemother; 1991 May; 35(5):967-71. PubMed ID: 1854178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials.
    Nielsen RW
    Am J Med; 1992 Jun; 92(6A):70S-73S. PubMed ID: 1621749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
    Zeckel ML
    Am J Med; 1992 Jun; 92(6A):58S-64S. PubMed ID: 1621746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of loracarbef (LY163892) versus amoxicillin in the treatment of bronchopneumonia and lobar pneumonia.
    Müller O; Wettich K
    Infection; 1992; 20(3):176-82. PubMed ID: 1463527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
    De Abate CA; Perrotta RJ; Dennington ML; Ziering RM
    J Chemother; 1992 Dec; 4(6):358-63. PubMed ID: 1287138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
    Gwaltney JM; Savolainen S; Rivas P; Schenk P; Scheld WM; Sydnor A; Keyserling C; Leigh A; Tack KJ
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1517-20. PubMed ID: 9210677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H
    Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness and tolerance of amoxicillin/clavulanic acid ("Augmentin") in intravenous injections in adults].
    el Filali KM; el M'Daghri N; el Kabli H; Hajji M; Benbachir M; Himmich H
    Pharmatherapeutica; 1989; 5(5):329-37. PubMed ID: 2748691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative United States and European trials of loracarbef in the treatment of acute otitis media.
    Foshee WS; Qvarnberg Y
    Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S12-9. PubMed ID: 1513607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
    Feldman W; Sutcliffe T; Dulberg C
    CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
    Powers RD
    Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.